Cost-effectiveness of screening for chronic hepatitis C infection in the United States
Targeted screening is cost-effective when prevalence of HCV exceeds 0.84%. Prospective evaluation of a screening tool is warranted and should include comparisons with other screening strategies.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency